Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation
- Cell. 2016 Sep 22;167(1):187-202.e17. doi: 10.1016/j.cell.2016.09.001.
- 1. Institute of Medical Biology, A(∗)STAR, Singapore 138632, Singapore; Institute of Molecular and Cellular Biology, A(∗)STAR, Singapore 138632, Singapore. Electronic address: [email protected].
- 2. Institute of Medical Biology, A(∗)STAR, Singapore 138632, Singapore; Laboratory of Human Cytogenetic, Molecular Genetics and Reproductive Biology, Farhat Hached University Hospital, Rue Ibn El Jazzar, 4000 Sousse, Tunisia.
- 3. Biozentrum, University of Basel, 4056 Basel, Switzerland.
- 4. Department of Dermatology and Venerology, Farhat Hached University Hospital, Rue Ibn El Jazzar, 4000 Sousse, Tunisia.
- 5. Institute of Molecular and Cellular Biology, A(∗)STAR, Singapore 138632, Singapore.
- 6. Institute of Medical Biology, A(∗)STAR, Singapore 138632, Singapore.
- 7. Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; St John's Institute of Dermatology, King's College London, Guy's Hospital, London SE1 4XA, United Kingdom.
- 8. Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia; Department of Medical Biology, The University of Melbourne, Parkville, Victoria 3010, Australia.
- 9. Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.
- 10. Ophthalmology Department, Hôpital Pierre-Paul Riquet, University Toulouse Hospital, TSA 40031, Place Baylac, 31059 Toulouse Cedex 9, France; Team Epithéliums, physiopathologie et génétique oculaires, Unité "Différenciation Epithéliale et Autoimmunité Rhumatoïde, UMR 1056 Inserm, Université Paul Sabatier Toulouse III, FRE 3742 CNRS, Hôpital Purpan, 31059 Toulouse Cedex 9, France.
- 11. Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
- 12. Institute of Medical Biology, A(∗)STAR, Singapore 138632, Singapore; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan.
- 13. Department of Dermatology, Venereology & Andrology, Faculty of Medicine, Alexandria University, Alexandria 21411, Egypt.
- 14. St John's Institute of Dermatology, King's College London, Guy's Hospital, London SE1 4XA, United Kingdom.
- 15. Department of Pathophysiology II, National Institute for Infectious Diseases "Matei Bals," "Carol Davila" University of Medicine and Pharmacy, Bucharest 050474, Romania.
- 16. Laboratory of Human Cytogenetic, Molecular Genetics and Reproductive Biology, Farhat Hached University Hospital, Rue Ibn El Jazzar, 4000 Sousse, Tunisia.
- 17. Institute of Medical Biology, A(∗)STAR, Singapore 138632, Singapore; Institute of Molecular and Cellular Biology, A(∗)STAR, Singapore 138632, Singapore; Medical Genetics Department, Koç University School of Medicine, 34010 Istanbul, Turkey; Department of Paediatrics, National University of Singapore, Singapore 119228, Singapore. Electronic address: [email protected].
Inflammasome complexes function as key innate immune effectors that trigger inflammation in response to pathogen- and danger-associated signals. Here, we report that germline mutations in the inflammasome sensor NLRP1 cause two overlapping skin disorders: multiple self-healing palmoplantar carcinoma (MSPC) and familial keratosis lichenoides chronica (FKLC). We find that NLRP1 is the most prominent inflammasome sensor in human skin, and all pathogenic NLRP1 mutations are gain-of-function alleles that predispose to inflammasome activation. Mechanistically, NLRP1 mutations lead to increased self-oligomerization by disrupting the PYD and LRR domains, which are essential in maintaining NLRP1 as an inactive monomer. Primary keratinocytes from patients experience spontaneous inflammasome activation and paracrine IL-1 signaling, which is sufficient to cause skin inflammation and epidermal hyperplasia. Our findings establish a group of non-fever inflammasome disorders, uncover an unexpected auto-inhibitory function for the pyrin domain, and provide the first genetic evidence linking NLRP1 to skin inflammatory syndromes and skin Cancer predisposition.